Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-083012
Filing Date
2026-02-27
Accepted
2026-02-27 16:47:10
Documents
93
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K aldx-20251231.htm   iXBRL 10-K 2842532
2 EX-10.27 aldx-ex10_27.htm EX-10.27 12450
3 EX-19.1 aldx-ex19_1.htm EX-19.1 278602
4 EX-21.1 aldx-ex21_1.htm EX-21.1 9002
5 EX-23.1 aldx-ex23_1.htm EX-23.1 4358
6 EX-31.1 aldx-ex31_1.htm EX-31.1 13690
7 EX-31.2 aldx-ex31_2.htm EX-31.2 13550
8 EX-32.1 aldx-ex32_1.htm EX-32.1 16723
9 EX-97 aldx-ex97.htm EX-97 53442
10 GRAPHIC img93524929_0.jpg GRAPHIC 185864
11 GRAPHIC img93524929_1.gif GRAPHIC 86242
12 GRAPHIC img93524929_2.gif GRAPHIC 66714
13 GRAPHIC img93524929_3.gif GRAPHIC 6557
14 GRAPHIC img93524929_4.gif GRAPHIC 8026
15 GRAPHIC img93524929_5.gif GRAPHIC 13797
16 GRAPHIC img93524929_6.gif GRAPHIC 46329
17 GRAPHIC img93524929_7.gif GRAPHIC 7026
  Complete submission text file 0001193125-26-083012.txt   11993980

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aldx-20251231.xsd EX-101.SCH 1373121
96 EXTRACTED XBRL INSTANCE DOCUMENT aldx-20251231_htm.xml XML 1771915
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36332 | Film No.: 26701082
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)